naltrexone and Intestinal Diseases

naltrexone has been researched along with Intestinal Diseases in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cantrell, BE; Gidda, JS; Johnson, BG; Leander, JD; Schoepp, DD; Zimmerman, DM	1
Candy, B; Jones, L; Larkin, PJ; Stone, P; Vickerstaff, V	1
Jackson, KC; Neyens, R	1
Boyce, D; Carr, DB; McNicol, ED; Schumann, R	1

Reviews

3 review(s) available for naltrexone and Intestinal Diseases

Article	Year
Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care. The Cochrane database of systematic reviews, 2018, 06-05, Volume: 6 Topics: Constipation; Defecation; Female; Gastrointestinal Agents; Humans; Intestinal Diseases; Male; Nalbuphine; Naloxone; Naltrexone; Narcotic Antagonists; Neoplasms; Opioid-Related Disorders; Oxycodone; Palliative Care; Piperidines; Quaternary Ammonium Compounds; Randomized Controlled Trials as Topic; Receptors, Opioid, mu	2018
Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus. Journal of pain & palliative care pharmacotherapy, 2007, Volume: 21, Issue:2 Topics: Analgesics, Opioid; Gastrointestinal Transit; Humans; Ileus; Intestinal Diseases; Naltrexone; Narcotic Antagonists; Piperidines; Postoperative Complications; Quaternary Ammonium Compounds	2007
Mu-opioid antagonists for opioid-induced bowel dysfunction. The Cochrane database of systematic reviews, 2008, Apr-16, Issue:2 Topics: Constipation; Defecation; Gastrointestinal Agents; Humans; Intestinal Diseases; Nalbuphine; Naloxone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Piperidines; Quaternary Ammonium Compounds; Receptors, Opioid, mu	2008

Other Studies

1 other study(ies) available for naltrexone and Intestinal Diseases

Article	Year
Discovery of a potent, peripherally selective trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonist for the treatment of gastrointestinal motility disorders. Journal of medicinal chemistry, 1994, Jul-22, Volume: 37, Issue:15 Topics: Animals; Diarrhea; Gastrointestinal Motility; Guinea Pigs; In Vitro Techniques; Intestinal Diseases; Male; Mice; Piperidines; Radioligand Assay; Receptors, Opioid, mu; Structure-Activity Relationship	1994

Article

Year

Discovery of a potent, peripherally selective trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonist for the treatment of gastrointestinal motility disorders.

Journal of medicinal chemistry, 1994, Jul-22, Volume: 37, Issue:15

Topics: Animals; Diarrhea; Gastrointestinal Motility; Guinea Pigs; In Vitro Techniques; Intestinal Diseases; Male; Mice; Piperidines; Radioligand Assay; Receptors, Opioid, mu; Structure-Activity Relationship

1994